Emerging evidence has validated the vital role of long non-coding RNA (lncRNA) in the chemoresistance of cancer treatment. In the present study, we investigate the function of lncRNA NR2F1-AS1 on oxaliplatin (OXA) resistance of hepatocellular carcinoma (HCC) and discover the underlying molecular mechanism. Results revealed that lncRNA NR2F1-AS1 was up-regulated in oxaliplatin-resistant HCC tis- --
| INTRODUCTION
Hepatocellular carcinoma (HCC) is one of the most common malignant tumours, accounting for a significant constituent part of cancerrelated death worldwide with an increase every year. 1, 2 HCC is a rapid growth and invasive tumour and has a tendency for high probability of metastasis and recurrence. 3 The prognosis of HCC patients is still pessimistic, and the 5-year survival rate is 30%-40% in China. 4 Traditional therapeutic methods for HCC, including surgical resection and chemoradiotherapy, are hard to completely solve the tumour progression. 5 Fundamentally, the molecular mechanisms for HCC metastasis need to sequentially explore.
Long non-coding RNA (lncRNA) is one type of the vital epigenetics regulatory mechanism, as well as DNA methylation and genomic imprinting. Emerging evidence has indicated the important role of lncRNA in the multiple cancer tumorigenesis, especially in HCC. 6, 7 For example, lncRNA UBE2CP3 was frequently up-regulated in HCC samples and promotes hepatocellular carcinoma tumour metastasis via regulating epithelial-mesenchymal transition and inducing cell invasion and migration. 8 LncRNA Igf2as was upregulated in HCC cells and tissues and controlled hepatocellular carcinoma progression through the ERK/MAPK signalling pathway. 9 Oxaliplatin resistance is one of the most vital barriers for HCC chemotherapy. LncRNAs have been proved to modulate the chemotherapy resistance of HCC on molecular level. For example, lncARSR is up-regulated in HCC and lncARSR overexpression enhances the doxorubicin resistance of HCC cells via modulating PTEN-PI3K/Akt pathway in vitro and in vivo. 10 In this study, we measure the expression levels of dysregulated lncRNAs in oxaliplatin-resistant HCC cells and determine the overex- per chamber by using an inverted microscope (Olympus, Japan). Each experiment was repeated three times.
| Dual-luciferase reporter assay
Dual-luciferase reporter assay was performed as described previously. 13 Briefly, the RNA sequence of NR2F1-AS1 and ABCC1 
| Western blot
Protein samples were extracted using radioimmunoprecipitation University. Animals were fed under sterile-specific pathogen-free conditions. About 1 9 10 6 cells were injected into the subcutaneous of mice. After 3 weeks, the mice were killed using cervical dislocation and tumour weight was measured.
| Statistical analysis
Quantitative value of NR2F1-AS1 expression levels and others was presented as the mean AE SD. Statistical significance was evaluated using multivariate analysis of variance (ANOVA) and Student's t test using GraphPad Prism (GraphPad Software, La Jolla, CA, United States). P < .05 was considered as statistically significant. 
| DISCUSSION
Hepatocellular carcinoma is an aggressive malignant tumour with the high recurrence rate. 15, 16 The clinical therapeutic effects of conventional methods are always unsatisfactory. 17 One of the most vital pathogen is chemoresistance of HCC cells against series of chemotherapeutic drug, including cisplatin, doxorubicin, oxaliplatin. 18 In the present Bioinformatics prediction tools are an emerging assistant method to help researchers discover the underlying molecular mechanism within lncRNA and protein mRNA. 26 By means of these online tools 
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